Harrow End Period Cash Flow from 2010 to 2024

HROW Stock  USD 38.08  1.94  4.85%   
Harrow Health End Period Cash Flow yearly trend continues to be fairly stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2024. During the period from 2010 to 2024, Harrow Health End Period Cash Flow regression line of quarterly data had mean square error of 502.5 T and geometric mean of  7,011,140. View All Fundamentals
 
End Period Cash Flow  
First Reported
2006-06-30
Previous Quarter
71 M
Current Value
72.6 M
Quarterly Volatility
22.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harrow Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health's main balance sheet or income statement drivers, such as Interest Expense of 22.4 M, Selling General Administrative of 87.2 M or Selling And Marketing Expenses of 37.7 M, as well as many indicators such as Price To Sales Ratio of 2.67, Dividend Yield of 6.0E-4 or PTB Ratio of 4.9. Harrow financial statements analysis is a perfect complement when working with Harrow Health Valuation or Volatility modules.
  
Check out the analysis of Harrow Health Correlation against competitors.
For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.

Latest Harrow Health's End Period Cash Flow Growth Pattern

Below is the plot of the End Period Cash Flow of Harrow Health over the last few years. It is Harrow Health's End Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harrow Health's overall financial position and show how it may be relating to other accounts over time.
End Period Cash Flow10 Years Trend
Slightly volatile
   End Period Cash Flow   
       Timeline  

Harrow End Period Cash Flow Regression Statistics

Arithmetic Mean23,740,938
Geometric Mean7,011,140
Coefficient Of Variation136.64
Mean Deviation26,046,333
Median8,211,492
Standard Deviation32,440,794
Sample Variance1052.4T
Range96.2M
R-Value0.75
Mean Square Error502.5T
R-Squared0.56
Significance0
Slope5,411,824
Total Sum of Squares14733.7T

Harrow End Period Cash Flow History

202477.8 M
202374.1 M
202296.3 M
202142.2 M
20204.3 M
20194.9 M
20186.8 M

About Harrow Health Financial Statements

Harrow Health investors use historical fundamental indicators, such as Harrow Health's End Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harrow Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
End Period Cash Flow74.1 M77.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.